Skip to main content
'New benchmark' set in phase-3 blood cancer study
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
'New benchmark' set in phase-3 blood cancer study
User login
Username
Password
Reset your password
Concept
Lead
score
Non-Hodgkin Lymphoma (NHL)
1
0.94
Lymphoma
0
0.93
Mantle Cell Lymphoma
0
0.92
Antineoplastic Drug
0
0.28
Cancer
0
0.26
Toxicology
0
0.22
Genomic Medicine
0
0.17
Blood
0
0.15
Stem Cell Research and Therapy
0
0.15
Clinical Research
0
0.1
Monoclonal Antibody
0
0.1
Transplantation
0
0.1
Biomedical Technology
0
0.05
California
0
0.05
Chemotherapy
0
0.05
Concerns of Elderly
0
0.05
Geriatrics
0
0.05
Texas
0
0.05
Tyrosine Kinase
0
0.05
Wisconsin
0
0.05
Multiple Myeloma
0
0.04
Neutropenia
0
0.04
Specialty
Lead
score
Hematology-Oncology
1
1
Pharmacist
0
0.93
Family Medicine/Primary Care
0
0.36
Emergency Medicine
0
0.28
Transplantation
0
0.18
Hospital Medicine
0
0.11
Edit Tags